← back to search

Se Jin Im

Sungkyunkwan University · KR
Area of research
Immunology · Oncology
Research interest
Research interests include Immune Cell Function and Interaction, Immunotherapy and Immune Responses, T-cell and B-cell Immunology, and Cancer Immunotherapy and Biomarkers.
h-index
23
citations
6,295
works
61
NIH funding
primary concept
email

Recent publications

PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors
Science Immunology 2023cited by 75position: middledoi
Characteristics and anatomic location of PD-1 <sup>+</sup> TCF1 <sup>+</sup> stem-like CD8 T cells in chronic viral infection and cancer
Proceedings of the National Academy of Sciences 2023cited by 73position: firstdoi
PD-1 combination therapy with IL-2 modifies CD8+ T cell exhaustion program
Nature 2022cited by 312position: middledoi
Functional HPV-specific PD-1+ stem-like CD8 T cells in head and neck cancer
Nature 2021cited by 341position: middledoi
Tumor-draining lymph node is important for a robust abscopal effect stimulated by radiotherapy
Journal for ImmunoTherapy of Cancer 2020cited by 170position: middledoi
PD-1+ stemlike CD8 T cells are resident in lymphoid tissues during persistent LCMV infection
Proceedings of the National Academy of Sciences 2020cited by 126position: firstdoi
Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
Immune Network 2020cited by 52position: firstdoi
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Nature 2019cited by 830position: middledoi
Proliferating Transitory T Cells with an Effector-like Transcriptional Signature Emerge from PD-1+ Stem-like CD8+ T Cells during Chronic Infection
Immunity 2019cited by 660position: middledoi
Epigenetic signature of PD-1+ TCF1+ CD8 T cells that act as resource cells during chronic viral infection and respond to PD-1 blockade
Proceedings of the National Academy of Sciences 2019cited by 216position: middledoi
CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions
Annual Review of Medicine 2018cited by 659position: middledoi
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Nature 2016cited by 2,048position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Rafi Ahmed · Emory University9 papers (2016–2023)Masao Hashimoto · Emory University5 papers (2016–2023)Haydn Kissick · Emory University5 papers (2016–2023)Tahseen H. Nasti · Emory University4 papers (2016–2023)Andreas Wieland · Emory and Henry College4 papers (2019–2023)William Henry Hudson · Baylor College of Medicine3 papers (2019–2023)Gordon J. Freeman · Harvard University3 papers (2016–2023)Suresh S. Ramalingam · Emory University2 papers (2018–2023)Peng Li · Tongji University2 papers (2019–2019)Warren J. Leonard · National Heart Lung and Blood Institute2 papers (2019–2019)Alice O. Kamphorst · Tisch Cancer Institute2 papers (2018–2023)Rebecca C. Obeng · University Hospitals of Cleveland2 papers (2021–2023)Bogumila T. Konieczny · Emory University2 papers (2019–2020)Helder I. Nakaya · Universidade de São Paulo2 papers (2016–2023)Christiane S. Eberhardt · University of Geneva2 papers (2020–2021)Jian-Xin Lin · National Heart Lung and Blood Institute2 papers (2019–2019)Koichi Araki · Cincinnati Children's Hospital Medical Center2 papers (2018–2023)Judong Lee · Emory University2 papers (2016–2020)Nataliya Prokhnevska · Icahn School of Medicine at Mount Sinai2 papers (2021–2023)André N. A. Gonçalves · Liverpool School of Tropical Medicine1 papers (2023–2023)